Effect of estrogen and testosterone replacement therapy on cognitive fatigue

Gynecological Endocrinology

Volumn 29, Issue 2, 2013, Pages 173-176

  Möller, Marika Christina ^a,b   Rådestad, Angelique Flöter ^c   Von Schoultz, Bo ^c   Bartfai, Aniko ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Estrogen; Fatigue; Hormone therapy; Oophorectomy; Psychological well being; Testosterone

Indexed keywords

ESTRADIOL VALERATE; ESTROGEN; PLACEBO; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COGNITIVE DEFECT; COGNITIVE FATIGUE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSTHYMIA; ESTROGEN BLOOD LEVEL; FEMALE; FOLLOW UP; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENTAL FUNCTION; NEUROPSYCHOLOGICAL TEST; OVARIECTOMY; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOLOGICAL GENERAL WELL BEING (PGWB); PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF EVALUATION; TESTOSTERONE BLOOD LEVEL; TREATMENT INDICATION; TREATMENT OUTCOME;

ALGORITHMS; ANDROGENS; BODY MASS INDEX; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENTAL FATIGUE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OVARIECTOMY; OVERWEIGHT; SALPINGECTOMY; SWEDEN; TESTOSTERONE;

EID: 84871409255     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.730568     Document Type: Article

References (30)

1. Boone KB. Fixed belief in cognitive dysfunction despite normal neuropsychological scores: neurocognitive hypochondriasis? Clin Neuropsychol 2009;23:1016-1036.
2. Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics 2008;49:185-190. (Pubitemid 351668718)
3. Zwarts MJ, Bleijenberg G, van Engelen BG. Clinical neurophysiology of fatigue. Clin Neurophysiol 2008;119:2-10.
4. Bachmann G, Braunstein G, Burger H, Dennerstein L, Leiblum S, et al. Female androgen insuf?ciency: the Princeton consensus statement on definition, classification, and assessment. Fertility and Sterility 2002;77:661-665.
5. Flöter A. Testosterone treatment in women-an overview. Current Womens Health Review 2009;5:29-43.
6. Davis SR. When to suspect androgen deficiency other than at menopause. Fertil Steril 2002;77 Suppl 4:S68-S71. (Pubitemid 34465847)
7. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48:S8-15. (Pubitemid 27230087)
8. Ahlbom E, Prins GS, Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res 2001;892:255-262. (Pubitemid 32141211)
9. Hammond J, Le Q, Goodyer C, Gelfand M, Trifiro M, LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem 2001;77:1319-1326. (Pubitemid 32523685)
10. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-1499. (Pubitemid 32221898)
11. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, et al.; Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968. (Pubitemid 38802685)
12. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, et al.; WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662. (Pubitemid 37430136)
13. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis 2010;7:163-166.
14. Hogervorst E, Matthews FE, Brayne C. Are optimal levels of testosterone associated with better cognitive function in healthy older women and men? Biochim Biophys Acta 2010;1800:1145-1152.
15. Sherwin BB. Androgens and cognitive functioning in women. In: Hogervorst E Henderson VW, Gibbs RB, Brinton RD (eds). Hormones, cognition and dementia: state of the art and emergent therapeutic strategies. Cambridge: Cambridge University Press, 2009, 179-186.
16. Muller M, Aleman A, Grobbee DE, de Haan EH, van der Schouw YT. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology 2005;64:866-871. (Pubitemid 40316327)
17. Moffat SD, Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology 1996;21:323-337. (Pubitemid 26246859)
18. Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler 2003;9:503-508. (Pubitemid 37287731)
19. DeLuca J. Fatigue: its definition, its study and its future. In: DeLuca J. editor. Fatigue as a window to the brain. Cambridge: MIT Press; 2005. pp 319-325.
20. Ashman TA, Cantor JB, Gordon WA, Spielman L, Egan M, Ginsberg A, Engmann C, et al. Objective measurement of fatigue following traumatic brain injury. J Head Trauma Rehabil 2008;23:33-40. (Pubitemid 351161169)
21. Kohl AD, Wylie GR, Genova HM, Hillary FG, Deluca J. The neural correlates of cognitive fatigue in traumatic brain injury using functional MRI. Brain Inj 2009;23:420-432.
22. Kaplan E, Fein D, Morris R, Delis DC: WAIS-R NI. WAIS-R som neuropsykologiskt instrument. Manual. Stockholm: Psykologiförlaget, 1994.
23. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5: 357-365. (Pubitemid 36149723)
24. Möller MC, Bartfai AB, Rådestad AF. Effects of testosterone and estrogen replacement on memory function. Menopause 2010;17:983-989.
25. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy. Maturitas 2004;47:123-129. (Pubitemid 38130194)
26. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J (eds.). Assessment of quality of life in cinical trials of cardiovascular therapies. New York: Le Jacq Publishing Inc., 1984: 170-183.
27. Lezak MD, Howieson DB, Hannay HJ. Neuropsychologsical assessment. 4th ed., New York: Oxford University Press, 2004.
28. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-810. (Pubitemid 13228095)
29. Lee IS, Bardwell WA, Ancoli-Israel S, Dimsdale JE. Number of lapses during the psychomotor vigilance task as an objective measure of fatigue. J Clin Sleep Med 2010;6:163-168.
30. Anandacoomarasamy A, Caterson ID, Leibman S, Smith GS, Sambrook PN, Fransen M, March LM. Influence of BMI on health-related quality of life: comparison between an obese adult cohort and age-matched population norms. Obesity (Silver Spring) 2009;17:2114-2118.